High Sensitive ELISA Kit for Wingless Type MMTV Integration Site Family, Member 3A (WNT3A)

Specificity

This assay has high sensitivity for detection of High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A).
100% cross-reactivity of High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) was observed among Human, Mouse, Rat.

Recovery

Matrices listed below were spiked with certain level of recombinant High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) and the recovery rates were calculated by comparing the measured value to the expected amount of High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 92-99 96
EDTA plasma(n=5) 89-101 92
heparin plasma(n=5) 87-95 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of High Sensitive Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-93% 82-98% 78-102% 81-92%
EDTA plasma(n=5) 90-104% 80-90% 92-104% 84-92%
heparin plasma(n=5) 80-98% 81-91% 93-103% 78-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Medical Oncology Wls promotes the proliferation of breast cancer cells via Wnt signaling Pubmed:25801232
J Histochem Cytochem Wnt3a Mediates the Inhibitory Effect of Hyperoxia on the Transdifferentiation of AECIIs to AECIs PubMed: 26209081
PloS one Gelatin device for the delivery of growth factors involved in endochondral ossification pubmed:28380024
Life Sciences Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. pubmed:28754618
Oxidative Medicine and Cellular Longevity Secreted Frizzled-Related Protein-2 Inhibits Doxorubicin Induced Apoptosis Mediated Through the Akt-mTOR Pathway in Soleus Muscle Pubmed:30151071
The Showa University Journal of Medical Sciences Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/β-catenin Signaling Pathway in Triple-negative Breast Cancer Doi: 10.15369/sujms.30.359
Journal of Cancer Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma Pubmed: 31737122
CANCER LETTERS Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection Pubmed: 32920199
Biomaterials An improved osseointegration of metal implants by pitavastatin loaded multilayer films with osteogenic and angiogenic properties 34823885
Catalog No. Related products for research use of Homo sapiens (Human), Mus musculus (Mouse), Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
SEP155Mi ELISA Kit for Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) Enzyme-linked immunosorbent assay for Antigen Detection.
HEP155Mi High Sensitive ELISA Kit for Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) Enzyme-linked immunosorbent assay for Antigen Detection.
SCP155Mi CLIA Kit for Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) Chemiluminescent immunoassay for Antigen Detection.
LMP155Mi Multiplex Assay Kit for Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.